Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types. Our approach has the potential to precisely direct different immune mediators against a range of target immune cell-types and create best-in-class immunotherapies in cancer, autoimmune and infectious diseases. Asher Bio is backed by Third Rock Ventures and is located in South San Francisco.
Location: United States, California, South San Francisco
Employees: 11-50
Total raised: $218M
Founded date: 2019
Investors 7
| Date | Name | Website |
| - | Emles Vent... | emlesventu... |
| - | Mission Bi... | missionbio... |
| 06.10.2020 | Y Combinat... | ycombinato... |
| 01.09.2021 | RA Capital... | racap.com |
| - | GoAhead Ve... | goaheadvc.... |
| 30.09.2021 | MBC BioLab... | mbcbiolabs... |
| - | For Good V... | forgoodven... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 17.04.2024 | Series C | $55M | - |
| 01.09.2021 | Series B | $108M | - |
| 23.03.2021 | Series A | $55M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 17.04.2024 | Asher Bio Closes $55M Series C Financing | Asher Bio, a San Francisco, CA-based biotechnology company developing precisely-targeted immunothera... | finsmes.co... |
| 14.09.2022 | YC’s 1st Health and Bio Summit | We’re excited to announce the first YC Health and Bio Summit that will take place in San Francisco o... | ycombinato... |
| 01.09.2021 | Asher Bio Closes $108 Million Series B Financing | Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for can... | marketscre... |
| 01.09.2021 | Asher Bio Raises $108M in Series B Funding | Asher Biotherapeutics, a South San Francisco CA-based biotechnology company, raised $108M in Series ... | finsmes.co... |
| 24.03.2021 | Daily funding roundup - March 24th, 2020 | Ginger raised $100M; Pacaso landed $75M; Ketch secured $23M; Kubecost picks up $5.5M Feedzai: Feedza... | vator.tv/n... |
| 23.03.2021 | Asher Bio Raises $55M in Series A Financing | Asher Biotherapeutics, a South San Francisco, Calif.-based biotechnology company developing precisel... | finsmes.co... |
| - | Asher Bio | “At Asher Biotherapeutics, we are pioneering a new approach with our cis‑targeted immunotherapies. O... | fastfounde... |